Marpai, Inc. (MRAI)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch MRAI
See up to 3 months of MRAI. The 7-day demo opens the 1M and 3M ranges and puts MRAI on your watchlist.
Start 7-day demoLatest MRAI insider trades
- Steve Andrew Johnson - OfficerOpen-market purchase$682
Yaron Eitan - DirectorOpen-market purchase$3K
About Marpai, Inc. (MRAI)
Marpai, Inc. files with the SEC under CIK 0001844392 and is classified as misc health and allied services, nec. It is grouped with Health Care companies on this site.
MRAI Form 4 activity by transaction type, last 90 days
No Form 4 activity for MRAI in the last 90 days.
MRAI insider transactions (Form 4)
5431 Form 4 filings on record, the earliest from Dec 9, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Yaron Eitan - Director | Derivative | Class A Common Stock | 50,000 footnote F1 | $0.00 | - | |
| Yaron Eitan - Director | Grant or award | Class A Common Stock | 175,000 footnote F2 | $0.00 | - | |
| ||||||
| Steve Andrew Johnson - Officer | Open-market purchase | Class A Common Stock | 1,100 | $0.62 | $682 | |
| Steve Andrew Johnson - Officer | Grant or award | Class A Common Stock | 125,000 footnote F1 | $0.00 | - | |
| ||||||
 Sagiv Shiv - Director | Derivative | Class A Common Stock | 50,000 footnote F1 | $0.00 | - | |
| Sagiv Shiv - Director | Grant or award | Class A Common Stock | 125,000 footnote F2 | $0.00 | - | |
| ||||||
| Robert M. Pons - Director | Derivative | Class A Common Stock | 50,000 footnote F1 | $0.00 | - | |
| Robert M. Pons - Director | Grant or award | Class A Common Stock | 100,000 footnote F2 | $0.00 | - | |
| ||||||
 Jennifer Rosario Calabrese - Director | Derivative | Class A Common Stock | 50,000 footnote F1 | $0.00 | - | |
| Jennifer Rosario Calabrese - Director | Grant or award | Class A Common Stock | 100,000 footnote F2 | $0.00 | - | |
| ||||||
 Damien Lamendola - Officer | Grant or award | Class A Common Stock | 300,000 footnote F1 | $0.00 | - | |
| ||||||
| Colleen Diclaudio - Director | Grant or award | Class A Common Stock | 125,000 footnote F1 | $0.00 | - | |
| ||||||
| Yaron Eitan - Director | Open-market purchase | Class A Common Stock | 10,000 | $0.27 | $3K | |
| Sagiv Shiv - Director | Grant or award | Class A Common Stock | 100,000 footnote F1 | $0.00 | - | |
| ||||||
| Yaron Eitan - Director | Open-market purchase | Class A Common Stock | 100,000 footnote F1 | $1.00 | $100K | |
| Yaron Eitan - Director | Open-market purchase | Common Warrants to purchase Shares of Common Stock | 200,000 | - footnote F1 | - | |
| ||||||
| Sagiv Shiv - Director | Open-market purchase | Class A Common Stock | 50,000 footnote F1 | $1.00 | $50K | |
| Sagiv Shiv - Director | Open-market purchase | Common Warrants to purchase Shares of Common Stock | 100,000 | - footnote F1 | - | |
| ||||||
| Dallas Scrip - Officer | Grant or award | Class A Common Stock | 100,000 footnote F1 | $1.00 | $100K | |
| Dallas Scrip - Officer | Open-market purchase | Common Warrants to purchase Shares of Common Stock | 200,000 | - footnote F1 | - | |
| ||||||
| Robert M. Pons - Director | Open-market purchase | Class A Common Stock | 50,000 | $1.00 footnote F1 | $50K | |
| Robert M. Pons - Director | Open-market purchase | Common Warrants to purchase Shares of Common Stock | 100,000 | - footnote F1 | - | |
| ||||||
| Damien Lamendola - Officer | Grant or award | Class A Common Stock | 550,000 footnote F1 | $0.00 | - | |
| ||||||
| Steve Andrew Johnson - Officer | Grant or award | Class A Common Stock | 275,000 footnote F1 | $0.00 | - | |
| ||||||
| Colleen Diclaudio - Director | Grant or award | Class A Common Stock | 75,000 footnote F1 | $0.00 | - | |
| ||||||
| Jennifer Rosario Calabrese - Director | Grant or award | Class A Common Stock | 50,000 footnote F1 | $0.00 | - | |
| ||||||
| Yaron Eitan - Director | Grant or award | Class A Common Stock | 125,000 footnote F1 | $0.00 | - | |
| ||||||
| Robert M. Pons - Director | Grant or award | Class A Common Stock | 50,000 footnote F1 | $0.00 | - | |
| Robert M. Pons - Director | Grant or award | Class A Common Stock | 75,000 footnote F2 | $0.00 | - | |
| Robert M. Pons - Director | Grant or award | Class A Common Stock | 100,000 footnote F3 | $0.00 | - | |
| ||||||
| Sagiv Shiv - Director | Grant or award | Class A Common Stock | 75,000 footnote F1 | $0.00 | - | |
| ||||||
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 10,000 | $1.43 | $14K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 10,000 | $1.43 | $14K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 20,000 | $1.40 | $28K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 20,000 | $1.40 | $28K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 20,000 | $1.40 | $28K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 20,000 | $1.40 | $28K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 20,000 | $1.40 | $28K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 20,000 | $1.40 | $28K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 10,000 | $1.42 | $14K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 10,000 | $1.42 | $14K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 14,000 | $1.63 | $23K | |
| Intelligent Fanatics Capital Management LLC - 10% Owner | Open-market sale | Common Shares, par value $0.0001 | 14,000 | $1.63 | $23K | |
| Damien Lamendola - Officer | Open-market purchase | Class A Common Stock | 147,058 | $1.36 | $200K | |
| Damien Lamendola - Officer | Open-market purchase | Class A Common Stock | 896,903 | $1.06 | $950K | |
| Jennifer Rosario Calabrese - Director | Grant or award | Class A Common Stock | 75,000 | $0.00 | - | |
| Yaron Eitan - Director | Grant or award | Class A Common Stock | 75,000 | $0.00 | - | |
| Sagiv Shiv - Director | Grant or award | Class A Common Stock | 75,000 | $0.00 | - | |
| Damien Lamendola - Officer | Open-market purchase | Class A Common Stock | 371,470 | $1.08 | $400K | |
| Damien Lamendola - Officer | Open-market purchase | Class A Common Stock | 86,805 | $1.15 | $100K | |
| John Paul Powers - Officer | Grant or award | Class A Common Stock | 100,000 | $0.00 | - | |
| John Paul Powers - Officer | Open-market purchase | Class A Common Stock | 10,000 | $1.13 | $11K | |
| Yaron Eitan - Director | Grant or award | Class A Common Stock | 5,000 | $0.00 | - | |
| Yaron Eitan - Director | Open-market purchase | Class A Common Stock | 110,619 | $1.13 | $125K | |
Item 1.01, 3.02, 5.03, 8.01, 9.01
Item 1.01, 8.01, 9.01
Item 1.01, 9.01
Item 1.01, 2.03, 9.01
MRAI insider trading FAQ
What is the latest insider trade for MRAI?
Marpai, Inc. (MRAI) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-02. The full record for MRAI runs to 31 Form 4 filings, the earliest from 2024-12-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MRAI stock?
No insider purchases of MRAI were filed in the last 90 days. 16 purchases are on record for this company.
How many insiders are selling MRAI stock?
No insider sales of MRAI were filed in the last 90 days. 12 sales are on record for this company.
Where can I see MRAI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MRAI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Yaron Eitan view on EDGAR
- - Steve Andrew Johnson view on EDGAR
- - Sagiv Shiv view on EDGAR
- - Robert M. Pons view on EDGAR
- - Jennifer Rosario Calabrese view on EDGAR
- - Damien Lamendola view on EDGAR
- - Colleen Diclaudio view on EDGAR
- - Yaron Eitan view on EDGAR
- - Sagiv Shiv view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where MRAI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MRAI with a 7-day demo
- MRAI on your watchlist
- Every MRAI Form 4 filing on record
- Up to 3 months of MRAI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
